The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Autonomix Medical, Inc. quarterly Earnings Per Share, Diluted in USD/shares history and change rate from 31 Dec 2022 to 31 Dec 2023.
Autonomix Medical, Inc. Earnings Per Share, Diluted for the quarter ending 31 Dec 2023 was -0.23, a 360% decline year-over-year.
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.